baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Omeros Corporation/ US6821431029 /

6/3/2024 4:56:33 PM	Chg. +0.4700	Volume	Bid4:59:12 PM	Ask4:59:12 PM	High	Low
3.8300USD	+13.99%	247,579 Turnover: 800,399.3307	3.8300Bid Size: 400	3.8400Ask Size: 200	3.9950	3.3901

GlobeNewswire 11/2/2023 vTv Therapeutics Appoints Thomas Strack, M.D., as Chief Medical Officer

GlobeNewswire 10/13/2023 US Nephrologists Embrace Current IgA Nephropathy Therapies, Yet a Thriving Pipeline Signals Fierce M...

GlobeNewswire 10/11/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporati...

GlobeNewswire 10/4/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporati...

GlobeNewswire 6/8/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporati...

GlobeNewswire 6/3/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporati...

GlobeNewswire 5/28/2021 Omeros Corporation Investors: Company Investigated by the Portnoy Law Firm

GlobeNewswire 5/27/2021 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporati...

GlobeNewswire 9/17/2020 XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer

GlobeNewswire 9/10/2020 Opthea Appoints US-Based Non-Executive Director

GlobeNewswire 8/7/2020 Dr James Khodabakhsh MD named Chairman of the Scientific Advisory Board at OKYO Pharma Ltd

GlobeNewswire 7/8/2020 Atossa Therapeutics Advances Product Development Programs with Multiple Key Hires in Clinical, Regul...

GlobeNewswire 2/3/2020 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporati...

GlobeNewswire 11/11/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporati...

GlobeNewswire 11/4/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporati...

GlobeNewswire 9/12/2019 Aimia Shareholders for Accountability Requisition Special Meeting to Reconstitute Board and Restore ...

GlobeNewswire 4/26/2019 Anemia Treatment Drugs: 2019 Global Market Study; Analyzed by Type of Anemia, Type of Drug, and Geog...

GlobeNewswire 4/16/2019 Investor Expectations to Drive Momentum within Washington Prime Group, Noble Midstream Partners LP, ...

GlobeNewswire 3/20/2019 Global Opioid Use Disorder (OUD) Opportunity Analysis and Forecasts 2018-2027: Experienced and New P...

GlobeNewswire 2/22/2019 Investor Expectations to Drive Momentum within Graphic Packaging Holding, Vulcan Materials, Omeros, ...

GlobeNewswire 1/3/2019 Investor Expectations to Drive Momentum within L3 Technologies, The Goldman Sachs Group, Genuine Par...

GlobeNewswire 12/17/2018 Chronic Respiratory Disease Drug Development Pipeline Review, 2018: Therapeutics Under Development a...

GlobeNewswire 8/28/2018 Detailed Research: Economic Perspectives on Allegheny Technologies, Ring Energy, Aerohive Networks, ...

GlobeNewswire 6/26/2018 Analysis: Positioning to Benefit within The Manitowoc, Omeros, Catabasis Pharmaceuticals, Zayo Group...

GlobeNewswire 6/21/2018 Report: Developing Opportunities within ABIOMED, Avid Technology, Unit, Omeros, Strayer Education, a...

Omeros Corporation/ US6821431029 /

If you wish to receive reply to your feedback, please provide your email address.